cepharanthine has been researched along with Breast Cancer in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (75.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ding, X; Gao, S; Li, X; Qi, W; Yang, Q | 1 |
Ono, M; Orita, K; Tanaka, N | 1 |
Hagiwara, M; Kanasugi, K; Komoriyama, H; Morikubo, M; Oikawa, H; Satoh, T; Tsukikawa, S; Yamaguchi, S | 1 |
Abe, R; Kimijima, I; Nihei, M; Nomizu, T; Suzuki, S; Tsuchiya, A | 1 |
1 trial(s) available for cepharanthine and Breast Cancer
Article | Year |
---|---|
[Efficacy of Cepharanthin for preventing leukopenia and thrombocytopenia induced by chemotherapy in breast cancer patient--prospective randomized study].
Topics: Alkaloids; Antineoplastic Combined Chemotherapy Protocols; Benzylisoquinolines; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Female; Humans; Leukopenia; Peptichemio; Prospective Studies; Randomized Controlled Trials as Topic; Thrombocytopenia | 1990 |
3 other study(ies) available for cepharanthine and Breast Cancer
Article | Year |
---|---|
Cepharanthine Induces Autophagy, Apoptosis and Cell Cycle Arrest in Breast Cancer Cells.
Topics: Apoptosis; Autophagy; Benzylisoquinolines; Breast Neoplasms; Cell Cycle Checkpoints; Female; Humans; MCF-7 Cells; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases | 2017 |
Positive interactions between human interferon and cepharanthin against human cancer cells in vitro and in vivo.
Topics: Alkaloids; Animals; Antineoplastic Combined Chemotherapy Protocols; Benzylisoquinolines; Breast Neoplasms; Cell Division; Colonic Neoplasms; Drug Screening Assays, Antitumor; Drug Synergism; Female; Interferon-beta; Interferon-gamma; Interferons; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Recombinant Proteins; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 1994 |
[The effect of cepharanthin on adjuvant chemotherapy induced bone marrow suppression in patients with breast cancer].
Topics: Alkaloids; Antineoplastic Combined Chemotherapy Protocols; Benzylisoquinolines; Bone Marrow; Breast Neoplasms; Female; Fluorouracil; Humans; Immunosuppressive Agents; Leukopenia; Middle Aged; Mitomycin; Mitomycins | 1990 |